During last month’s Joint Meeting of the Anesthetic and Life Drugs Advisory Committee (ALSDAC) & Drug Safety and Risk Management Advisory Committee (DSaRM), the Accreditation Council for Pharmacy Education (ACPE) delivered comments regarding Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics. The presentation, which was delivered by ACPE Executive Director Peter […]
